Why You've Stopped Losing Weight on Mounjaro

Is this a true plateau, or has loss just slowed right down?

Before concluding that Mounjaro has stopped working, it's worth separating a genuine plateau from a natural deceleration. Early in treatment, when tirzepatide is first suppressing appetite meaningfully, weight tends to fall quickly. That rate rarely continues at the same pace indefinitely. The body is always recalculating: as you lose mass, your resting energy requirement falls too, so the same daily calories produce less of a deficit than they did at the start.

A quick habit worth building: weigh yourself at the same time of day, on the same day each week, after using the bathroom and before eating. A single week of no change can reflect water retention, digestive timing, hormonal fluctuation, or even a heavier training session. A pattern of no change across four to six weeks is more meaningful. The typical weight-loss trajectory on Mounjaro involves variability even in strong responders, so weekly snapshots can mislead where a monthly average would reassure.

If the pause is three or four weeks and everything else is consistent, your body may simply be consolidating. Give it time before concluding anything.

Why does the body resist further weight loss even on an effective medicine?

Tirzepatide works through two gut-hormone pathways (GIP and GLP-1) slowing gastric emptying and reducing appetite, making it the only dual-agonist weight-loss medicine licensed in the UK. But it doesn't override metabolic adaptation entirely. When calorie intake falls and weight drops, the body responds by reducing output: movement becomes slightly more efficient, non-exercise activity decreases imperceptibly, and appetite-regulating hormones push back. This is well-documented biology, not personal failure.

Alongside that, appetite suppression can subtly ease as your system adapts to a given dose. You may find that portion sizes have drifted upward compared with your first weeks on treatment, not dramatically, but enough to close the gap. This is sometimes called diet drift, and it happens without people noticing it consciously. Research across the SURMOUNT clinical programme, which involved thousands of adults using tirzepatide over 72 weeks, shows that weight loss continues longest in people who maintain attention to their eating patterns alongside the medicine. The full clinical profile of tirzepatide covers the evidence in more detail.

Stress, poor sleep and certain medications can also suppress progress. They're worth considering as part of the picture, and your prescriber or GP can help you assess them.

Does a stall at your current dose mean you should move up?

Mounjaro is titrated in steps (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg) with the intention that the prescriber increases the dose as tolerated. If you have stopped losing weight on Mounjaro after several weeks at a particular dose, especially if it's not yet the highest dose you've been prescribed, your system may simply be ready for the next step. Only a prescriber who has reviewed your current dose, your side-effect profile, and your weight trajectory can make that call.

This is why the clinical review before every repeat matters. At nume, a GPhC-registered Independent Prescriber reads your consultation before each order is processed, a real clinician, not an automated system. If you're stalling and you're not yet at your maximum dose, that conversation is exactly what the review is for. You can also reach the aftercare team directly through our support line, which is available seven days a week.

Importantly, NICE guidance on tirzepatide (TA1026) notes that if a patient achieves less than 5% weight loss after six months at their highest tolerated dose, continuing is subject to clinical review. That threshold applies to maximum tolerated dose, not to an intermediate step where a dose increase hasn't yet been tried.

What practical steps are worth trying before assuming the medicine isn't working?

There are a few evidence-consistent adjustments that may help shift a plateau, all of which sit within the lifestyle component of treatment. Protein intake is the most commonly overlooked: on a lower calorie intake, adequate protein protects muscle mass and keeps satiety high. Aiming for enough protein at each meal (the specific amount depends on your size and activity level, so a prescriber or dietitian can guide you) is worth prioritising over calorie restriction alone.

Resistance exercise deserves mention too. Aerobic activity burns calories directly; strength training rebuilds or preserves muscle, which keeps metabolic rate higher as weight falls. Even two sessions a week of body-weight exercises can make a measurable difference to body composition over months, even when the scales move slowly.

For context on what treatment alongside lifestyle support typically involves, the weight management overview covers both the clinical and practical sides. If you have noticed that weight loss has stopped on Mounjaro and are weighing up the cost of continuing private treatment, the Mounjaro cost page explains what a transparent private prescription typically includes. And if after reviewing all of the above you're wondering whether a different approach to treatment might suit you better, checking your eligibility with our prescribers is the right starting point.

The NHS guidance on tirzepatide and the clinical framework set out by NICE in TA1026 both treat plateau management as part of ongoing clinical care, not an emergency, but a conversation worth having sooner rather than later. Some people also notice unexpected changes such as shifts in body odor while taking Mounjaro, which can be worth raising with your prescriber as part of that broader review.